Scientific expertise for better health decisions

Health economic, statistical and decision evaluation

Statésia supports healthcare stakeholders in evaluating innovative products, technologies and strategies, from evidence to decision.

Explore our expertise Contact us

Our areas of expertise

Robust methods, from evidence to decision

01Network meta-analysisMixed treatment comparisons, Bayesian methods and NMA.→ 02Health economic modellingCost-effectiveness, budget impact and decision models.→ 03Real-world evidenceCohorts, SNDS, econometrics and care pathways.→ 04Open Data & Data ScienceOpen data, R, Python and statistical analysis.→

Health economics and Statistics

Welcome!

Statésia is a research and consulting firm specialized in comparative effectiveness research and medico-economic analysis of health technologies and strategies (for hospitals, drug and medical device manusfacturers, consultancy firms, health institutions, HAS DEAI, CT, CEESP, CEPS).

This decision analysis is based on:

1- Comparative Effectiveness Research, Indirect and Mixed Treatment Comparisons (MTC, NMA) : Positioning your innovative technology in the studied therapeutic area;

2- Interactive Health Economics Modeling: Assessing the cost-effectiveness, the cost-utility or the cost-benefit of your innovative health product or technology;

3- Interactive Budget Impact Analysis (IBIA) : Assessing the affordability of your innovative product;

4- Medico-economic real life studies.

FaLang translation system by Faboba

References and publications

Scientific work supporting concrete decisions

Study reports, publications, conferences and posters: explore Statésia’s work.

View references

A project?

Do you have a health economic or statistical evaluation project?

Let’s discuss your objectives, data and the most appropriate methodological framework.